Please login to the form below
Lars Rebien Sørensen becomes chairman of Novo Holdings
He will take up the new role 1 July
Former Novo Nordisk CEO Lars Rebien Sørensen has been appointed as Novo Holdings’ new chairman.
He said: “In recent years, Novo Holdings has significantly increased its investments and influence in the global life science sector.
“I consider it to be a great responsibility to lead the continued growth of Novo Holdings as it plans to further increase its investments in life science companies in the coming years.
Sørensen will succeed Sten Scheibye - who retires effective 1 July - and he will also become chairman of the board of the Novo Nordisk Foundation.
Featured jobs
-
Account Director, Medical Education
-
Salary TBC
- Account Manager, Medical Communications and Marketing
-
£30, 000 – £40, 000 benefits and bonus
-
Senior Medical Writer
-
Salary TBC
- Editorial Assistant Medical Education Agency
-
£25, 000 - £26, 000
-
Senior Medical Writer
-
Great salary and benefits
-
Project Manager/ Account Manager
-
Salary TBC
-
Digital Account Director
-
Salary TBC
-
Senior Medical Writer
-
Up to £50, 000 with Benefits
Subscribe to our email news alerts
- Drug launches to watch in 2019
- Novartis first to benefit from NICE advice on ‘patient preference’
- GW Pharma's cannabis-based medicine to be tested in dementia
- Immuno-oncology in 2019: the rapid evolution continues
- Novartis’ Egatan gains US approval for neglected tropical disease
- Keytruda combo outshines Opdivo in kidney cancer
- Forster Communications and Cello Health launch sustainability service
- Excellent teamwork and interdepartmental collaboration lead to double promotion at Porterhouse Medical
- New ‘NHSX’ unit will lead health service digital transformation
- Gyroscope's gene therapy given to first dry AMD patient
- Roche’s rival to Bayer’s Vitrakvi gets speedy FDA review
- ‘Inflexible’ NICE blocking access to rare disease drugs
PMHub
M&F Health
M&F Health is a full service communications agency, dedicated to the health and wellbeing sector. We are an independent amongst...
Latest intelligence
- 2019: CRISPR and therapeutic gene editing comes of age
- Can gene-editing deliver safe and effective therapeutics for patients with intractable diseases?...
- The 10-year Web Challenge
- Understanding your users’ needs is more critical online today than ever. A site should mould itself around these insights, deliver those needs quickly, efficiently and with plenty of white space....
- Downloadable Pack: Understanding Multiple Sclerosis
- Inside this downloadable pack, you’ll find a wealth of exclusive information on the way multiple sclerosis is commonly treated today. As well as areas of continuous improvement for the industry....
Quick links
Infographics
